Merck KGaA Appoints Allan Gabor as Managing Director in China
December 12 2017 - 5:17AM
Dow Jones News
By Marc Navarro Gonzalez
Merck KGaA (MRK.XE) said on Tuesday that Allan Gabor will
succeed Alasdair Jelfs as managing director for the company in
China as of Feb. 1, 2018.
The German company said Mr. Gabor would also take over
operational responsibility for the performance materials business
in China.
Additionally, Mr. Gabor will become a permanent member of the
performance materials leadership team, Merck KGaA said.
Mr. Jelfs take up duties at company headquarters in Darmstadt,
Germany, the company said.
Mr. Gabor joined Merck KGaA in 2013, and is currently head of
the biopharma business in Asia, including China. Prior to joining
the company, Mr. Gabor was head of Pfizer in China.
Write to Marc Navarro Gonzalez at
marc.navarrogonzalez@dowjones.com
(END) Dow Jones Newswires
December 12, 2017 05:02 ET (10:02 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.